Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness

Authors: Sun-Seog Kweon, Min-Ho Shin, Young-Hoon Lee, Jin-Su Choi, Hae-Sung Nam, Kyeong-Soo Park, Do-Hyung Kim, Seul-Ki Jeong

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

High normal values of urine albumin-to-creatinine ratio (UACR) have been reported to have predictive values for hypertension, incident stroke, and higher mortality in the general population. This study aimed to investigate the association between normal ranges of UACR and carotid intima-media thickness (CIMT) in adult population.

Methods

We performed a cross-sectional study in adults aged 45 to 74 years who were living in Namwon City, South Korea. Both common CIMTs were measured, and mean values were calculated. Normal values of UACR were defined as <30mg/g and categorized into quintiles; less than 6.50, 6.51-9.79, 9.80-13.49, 13.50-18.89, and more than 18.90 mg/g. The association between the quintiles of UACR and common CIMT was analyzed and stratified by sex.

Results

A total of 7555 participants (3084 men and 4471 women) with normal UACR were enrolled in the present study. Common CIMT was positively and independently associated with increasing quintiles of UACR in men and women, even after adjusting for potential confounders including age and cardiovascular risk factors. Compared to the first quintile, the fifth quintile showed odds ratios of 1.80 (95% confidence intervals, 1.26-2.55) and 1.97 (1.28-3.04) for increased CIMT (>0.9mm) in men and women, respectively.

Conclusion

Higher UACR values within normal ranges (<30 mg/g) were positively and independently associated with CIMT in a Korean general population, suggesting that higher normal values of UACR might be a risk marker of subclinical carotid atherosclerosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference W.H.O: WHO report. Global burden of disease (GBD). 2004 W.H.O: WHO report. Global burden of disease (GBD). 2004
2.
go back to reference Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999, 22: 99-111.CrossRef Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999, 22: 99-111.CrossRef
3.
go back to reference Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int. 2006, 69: 2057-2063. 10.1038/sj.ki.5000377.CrossRefPubMed Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG: Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int. 2006, 69: 2057-2063. 10.1038/sj.ki.5000377.CrossRefPubMed
4.
go back to reference Abdelhafiz AH, Ahmed S, El Nahas M: Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol. 2011, 119 (Suppl 1): e6-e10.CrossRefPubMed Abdelhafiz AH, Ahmed S, El Nahas M: Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol. 2011, 119 (Suppl 1): e6-e10.CrossRefPubMed
5.
go back to reference Glassock RJ: Is the presence of microalbuminuria a relevant marker of kidney disease?. Curr Hypertens Rep. 2010, 12: 364-368. 10.1007/s11906-010-0133-3.PubMedCentralCrossRefPubMed Glassock RJ: Is the presence of microalbuminuria a relevant marker of kidney disease?. Curr Hypertens Rep. 2010, 12: 364-368. 10.1007/s11906-010-0133-3.PubMedCentralCrossRefPubMed
6.
go back to reference Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke. 2010, 41: 2625-2631. 10.1161/STROKEAHA.110.581215.CrossRefPubMed Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke. 2010, 41: 2625-2631. 10.1161/STROKEAHA.110.581215.CrossRefPubMed
7.
go back to reference Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 1996, 27: 2033-2039. 10.1161/01.STR.27.11.2033.CrossRefPubMed Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 1996, 27: 2033-2039. 10.1161/01.STR.27.11.2033.CrossRefPubMed
8.
go back to reference Jessani S, Levey AS, Chaturvedi N, Jafar TH: High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant. 2011, 10.1093/ndt/gfr200. Jessani S, Levey AS, Chaturvedi N, Jafar TH: High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant. 2011, 10.1093/ndt/gfr200.
9.
go back to reference Lee M, Saver JL, Chang KH, Ovbiagele B: Level of albuminuria and risk of stroke: systematic review and meta-analysis. Cerebrovasc Dis. 2010, 30: 464-469. 10.1159/000317069.PubMedCentralCrossRefPubMed Lee M, Saver JL, Chang KH, Ovbiagele B: Level of albuminuria and risk of stroke: systematic review and meta-analysis. Cerebrovasc Dis. 2010, 30: 464-469. 10.1159/000317069.PubMedCentralCrossRefPubMed
10.
go back to reference Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375: 2073-2081.CrossRef Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375: 2073-2081.CrossRef
11.
go back to reference Polak JF, Backlund JY, Cleary PA, Harrington AP, O’Leary DH, Lachin JM, Nathan DM: Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2011, 60: 607-613. 10.2337/db10-0296.PubMedCentralCrossRefPubMed Polak JF, Backlund JY, Cleary PA, Harrington AP, O’Leary DH, Lachin JM, Nathan DM: Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2011, 60: 607-613. 10.2337/db10-0296.PubMedCentralCrossRefPubMed
12.
go back to reference Mykkanen L, Zaccaro DJ, O’Leary DH, Howard G, Robbins DC, Haffner SM: Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 28, 28: 1710-1716.CrossRef Mykkanen L, Zaccaro DJ, O’Leary DH, Howard G, Robbins DC, Haffner SM: Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 28, 28: 1710-1716.CrossRef
13.
go back to reference Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007, 115: 459-467. 10.1161/CIRCULATIONAHA.106.628875.CrossRefPubMed Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007, 115: 459-467. 10.1161/CIRCULATIONAHA.106.628875.CrossRefPubMed
14.
go back to reference Nam HS, Shin MH, Zmuda JM, Leung PC, Barrett-Connor E, Orwoll ES, Cauley JA: Race/ethnic differences in bone mineral densities in older men. Osteoporos Int. 2010, 21: 2115-2123. 10.1007/s00198-010-1188-3.PubMedCentralCrossRefPubMed Nam HS, Shin MH, Zmuda JM, Leung PC, Barrett-Connor E, Orwoll ES, Cauley JA: Race/ethnic differences in bone mineral densities in older men. Osteoporos Int. 2010, 21: 2115-2123. 10.1007/s00198-010-1188-3.PubMedCentralCrossRefPubMed
15.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
16.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed
17.
go back to reference Choi SW, Kim HY, Lee YH, Ryu SY, Kweon SS, Rhee JA, Choi JS, Shin MH: eGFR is associated with subclinical atherosclerosis independent of albuminuria: The Dong-gu Study. Atherosclerosis. 2010, 212: 661-667. 10.1016/j.atherosclerosis.2010.06.039.CrossRefPubMed Choi SW, Kim HY, Lee YH, Ryu SY, Kweon SS, Rhee JA, Choi JS, Shin MH: eGFR is associated with subclinical atherosclerosis independent of albuminuria: The Dong-gu Study. Atherosclerosis. 2010, 212: 661-667. 10.1016/j.atherosclerosis.2010.06.039.CrossRefPubMed
18.
go back to reference Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005, 68: 228-236. 10.1111/j.1523-1755.2005.00397.x.CrossRefPubMed Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M: Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005, 68: 228-236. 10.1111/j.1523-1755.2005.00397.x.CrossRefPubMed
19.
go back to reference Sung JK, Kim JY, Youn YJ, Lee JW, Ahn SG, Yoo BS, Lee SH, Yoon J, Choe KH, Yoon JH, Park JK, Koh SB: Urine albumin creatinine ratio is associated with carotid atherosclerosis in a community based cohort: atherosclerosis risk of rural area in Korean general population study. J Cardiovasc Ultrasound. 2010, 18: 134-138. 10.4250/jcu.2010.18.4.134.PubMedCentralCrossRefPubMed Sung JK, Kim JY, Youn YJ, Lee JW, Ahn SG, Yoo BS, Lee SH, Yoon J, Choe KH, Yoon JH, Park JK, Koh SB: Urine albumin creatinine ratio is associated with carotid atherosclerosis in a community based cohort: atherosclerosis risk of rural area in Korean general population study. J Cardiovasc Ultrasound. 2010, 18: 134-138. 10.4250/jcu.2010.18.4.134.PubMedCentralCrossRefPubMed
20.
go back to reference Yu Z, Schneck M, Jacobs DR, Liu K, Allison M, O'Leary D, Durazo R, Darwin C, Kramer H: Association of carotid intima-media thickness with progression of urine albumin-creatinine ratios in The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2011, 57: 62-70. 10.1053/j.ajkd.2010.08.014.CrossRefPubMed Yu Z, Schneck M, Jacobs DR, Liu K, Allison M, O'Leary D, Durazo R, Darwin C, Kramer H: Association of carotid intima-media thickness with progression of urine albumin-creatinine ratios in The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2011, 57: 62-70. 10.1053/j.ajkd.2010.08.014.CrossRefPubMed
21.
go back to reference Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, Szeto CC: Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol. 2008, 158: 317-322. 10.1530/EJE-07-0708.CrossRefPubMed Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, Szeto CC: Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol. 2008, 158: 317-322. 10.1530/EJE-07-0708.CrossRefPubMed
22.
go back to reference Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M: The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2010, 9: 18-10.1186/1475-2840-9-18.PubMedCentralCrossRefPubMed Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M: The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2010, 9: 18-10.1186/1475-2840-9-18.PubMedCentralCrossRefPubMed
23.
go back to reference Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes. 2002, 51: 1157-1165. 10.2337/diabetes.51.4.1157.CrossRefPubMed Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes. 2002, 51: 1157-1165. 10.2337/diabetes.51.4.1157.CrossRefPubMed
24.
go back to reference Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT: Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation. 2004, 110: 2918-2923. 10.1161/01.CIR.0000147540.88559.00.CrossRefPubMed Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT: Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation. 2004, 110: 2918-2923. 10.1161/01.CIR.0000147540.88559.00.CrossRefPubMed
25.
go back to reference Pontremoli R, Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Ravera M, Tomolillo C, Deferrari G: Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. J Am Soc Nephrol. 2004, 15 (Suppl 1): S34-S36.CrossRefPubMed Pontremoli R, Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Ravera M, Tomolillo C, Deferrari G: Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. J Am Soc Nephrol. 2004, 15 (Suppl 1): S34-S36.CrossRefPubMed
26.
go back to reference Katakami N, Kim YS, Kawamori R, Yamasaki Y: The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation. 2010, 121: 2584-2591. 10.1161/CIRCULATIONAHA.109.892414.CrossRefPubMed Katakami N, Kim YS, Kawamori R, Yamasaki Y: The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation. 2010, 121: 2584-2591. 10.1161/CIRCULATIONAHA.109.892414.CrossRefPubMed
27.
go back to reference Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B: Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2006, 1: 940-951. 10.2215/CJN.00240106.CrossRefPubMed Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B: Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2006, 1: 940-951. 10.2215/CJN.00240106.CrossRefPubMed
28.
go back to reference Yanagawa T, Araki A, Sasamoto K, Shirabe S, Yamanouchi T: Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes. Metabolism. 2004, 53: 353-357. 10.1016/j.metabol.2003.10.025.CrossRefPubMed Yanagawa T, Araki A, Sasamoto K, Shirabe S, Yamanouchi T: Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes. Metabolism. 2004, 53: 353-357. 10.1016/j.metabol.2003.10.025.CrossRefPubMed
29.
go back to reference Fredrickson SK, Ferro TJ, Schutrumpf AC: Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care. 2004, 27: 1754-1755. 10.2337/diacare.27.7.1754.CrossRefPubMed Fredrickson SK, Ferro TJ, Schutrumpf AC: Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care. 2004, 27: 1754-1755. 10.2337/diacare.27.7.1754.CrossRefPubMed
30.
go back to reference Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, Schwandt P, Ludwig M: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007, 1: 97-106. 10.1177/1753944707085982.CrossRefPubMed Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, Schwandt P, Ludwig M: Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007, 1: 97-106. 10.1177/1753944707085982.CrossRefPubMed
31.
go back to reference Zhao B, Liu Y, Zhang Y, Chen Y, Yang Z, Zhu Y, Zhan W: Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study. Cardiovasc Diabetol. 2012, 11: 51-10.1186/1475-2840-11-51.PubMedCentralCrossRefPubMed Zhao B, Liu Y, Zhang Y, Chen Y, Yang Z, Zhu Y, Zhan W: Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study. Cardiovasc Diabetol. 2012, 11: 51-10.1186/1475-2840-11-51.PubMedCentralCrossRefPubMed
32.
go back to reference Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O’Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, et al: Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012, 308: 796-803. 10.1001/jama.2012.9630.CrossRefPubMed Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O’Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, et al: Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA. 2012, 308: 796-803. 10.1001/jama.2012.9630.CrossRefPubMed
33.
go back to reference Nishida Y, Takahashi Y, Nakayama T, Soma M, Asai S: Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study. Cardiovasc Diabetol. 2011, 10: 74-10.1186/1475-2840-10-74.PubMedCentralCrossRefPubMed Nishida Y, Takahashi Y, Nakayama T, Soma M, Asai S: Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study. Cardiovasc Diabetol. 2011, 10: 74-10.1186/1475-2840-10-74.PubMedCentralCrossRefPubMed
34.
go back to reference Keidar S, Kaplan M, Hoffman A, Aviram M: Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis. 1995, 115: 201-215. 10.1016/0021-9150(94)05514-J.CrossRefPubMed Keidar S, Kaplan M, Hoffman A, Aviram M: Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis. 1995, 115: 201-215. 10.1016/0021-9150(94)05514-J.CrossRefPubMed
35.
go back to reference Eknoyan G: Obesity and chronic kidney disease. Nefrologia. 2011, 31: 397-403.PubMed Eknoyan G: Obesity and chronic kidney disease. Nefrologia. 2011, 31: 397-403.PubMed
36.
go back to reference Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002, 13: 1034-1039.PubMed Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002, 13: 1034-1039.PubMed
37.
go back to reference Cirillo M, Laurenzi M, Mancini M, Zanchetti A, De Santo NG: Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension. 2006, 47: 56-61.CrossRefPubMed Cirillo M, Laurenzi M, Mancini M, Zanchetti A, De Santo NG: Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension. 2006, 47: 56-61.CrossRefPubMed
38.
go back to reference Rocco A, Heerlein K, Diedler J, Sykora M, Barrows R, Hacke W, Steiner T: Microalbuminuria in cerebrovascular disease: a modifiable risk factor?. Int J Stroke. 2010, 5: 30-34.CrossRefPubMed Rocco A, Heerlein K, Diedler J, Sykora M, Barrows R, Hacke W, Steiner T: Microalbuminuria in cerebrovascular disease: a modifiable risk factor?. Int J Stroke. 2010, 5: 30-34.CrossRefPubMed
39.
go back to reference Knopman DS: Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol. 2010, 171: 287-289. 10.1093/aje/kwp429. author reply 290-281PubMedCentralCrossRefPubMed Knopman DS: Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol. 2010, 171: 287-289. 10.1093/aje/kwp429. author reply 290-281PubMedCentralCrossRefPubMed
40.
go back to reference Barzilay JI, Gao P, O’Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S: Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med. 2011, 171: 142-150. 10.1001/archinternmed.2010.502.CrossRefPubMed Barzilay JI, Gao P, O’Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S: Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med. 2011, 171: 142-150. 10.1001/archinternmed.2010.502.CrossRefPubMed
41.
go back to reference Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, Kissela B, Unverzagt F, Howard G, Warnock D, McClellan W: Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis. 2011, 58: 756-763. 10.1053/j.ajkd.2011.05.027.CrossRefPubMed Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, Kissela B, Unverzagt F, Howard G, Warnock D, McClellan W: Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis. 2011, 58: 756-763. 10.1053/j.ajkd.2011.05.027.CrossRefPubMed
42.
go back to reference Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J: Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol. 2012, 7: 437-443. 10.2215/CJN.05330611.PubMedCentralCrossRefPubMed Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J: Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol. 2012, 7: 437-443. 10.2215/CJN.05330611.PubMedCentralCrossRefPubMed
Metadata
Title
Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness
Authors
Sun-Seog Kweon
Min-Ho Shin
Young-Hoon Lee
Jin-Su Choi
Hae-Sung Nam
Kyeong-Soo Park
Do-Hyung Kim
Seul-Ki Jeong
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-112

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue